Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00179205 · ClinicalTrials.gov registry record · Phase 2
Complementary Intradialytic Nutritional Supplementation in Dialysis Patients
A Phase 2 study, sponsored by Vanderbilt University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 27
- Enrollment target
NCT00179205 is a Phase 2 study that was terminated before completion, run by Vanderbilt University. The registered enrollment target is 27 participants.
The verdict
NCT00179205, a Phase 2 study, was terminated before completion, sponsored by Vanderbilt University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 27 participants
- Enrollment target
Study Summary
In this study, the investigators hypothesize that long-term administration of adequate intradialytic oral nutritional supplementation will increase visceral protein concentrations and somatic protein stores in malnourished chronic hemodialysis patients.
Interventions
- DRUG placebo
- DRUG Nepro nutritional supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2005-05 |
| Est. Completion | 2007-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00179205
The ClinicalTrials.gov registry entry for NCT00179205 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00179205 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00179205 about?
NCT00179205 is a clinical study titled "Complementary Intradialytic Nutritional Supplementation in Dialysis Patients". In this study, the investigators hypothesize that long-term administration of adequate intradialytic oral nutritional supplementation will increase visceral protein concentrations and somatic protein stores in malnourished chronic hemodialysis patients.
What is the current status of trial NCT00179205?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 27 participants. The study started on 2005-05. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00179205?
The interventions under investigation include: placebo (DRUG), Nepro nutritional supplement (DRUG).
Who is sponsoring clinical trial NCT00179205?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.